Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is ...

The FDA has accepted the NDA for paltusotine for the treatment and long-term maintenance of acromegaly in adults.

Paltusotine was granted orphan drug designation for the treatment of acromegaly by the FDA in July 2020. Orphan drug ...

Pharmaceuticals announced the U.S. Food and Drug Administration, FDA, accepted its New Drug Application, NDA, for ...

Crinetics Pharmaceuticals, Inc. (CRNX) announced the FDA accepted its New Drug Application for investigational candidate paltusotine ...

New World screwworm was largely eradicated from the U.S. and Central America in the 1960s and 1980s, respectively. But the ...

The company’s main innovation is the RaniPill™ capsule, a technology designed to replace injectable drugs with oral alternatives. Its product’s therapeutic areas include neuroendocrine tumors (NETs), ...

Treatments for mental health conditions are structured around the condition being treated and typically are holistic in nature- including not just medication but also other interventions, such as ...

Anti-seizure medications, which are also called anticonvulsants or anti-epileptic drugs (AEDs), are medications used to prevent seizures for people who have epilepsy. All AEDs are available only by ...

Somatostatin analogues are clinically used for the treatment of acromegaly and have the benefit ... retinoic acid in Cushing's syndrome. This medication is teratogenic and is not currently ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on December 10, 2024, the Compensation Committee of the ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. The role of ...